NCT05939752View on ClinicalTrials.gov

Cardiovascular Complications of Ibrutinib Therapy

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Ibrutinib Treatment
Interventions
OTHER

ophthalmological examination

OCT-retinal angiography At inclusion, 3 months and 6 months

BIOLOGICAL

blood test

"a 2-mL tube of blood will be taken to test for blood markers predisposing to cardiovascular complications.~At inclusion"

Trial Locations (1)

21000

RECRUITING

Chu Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER